GB2572359A - Method and device for collecting, preserving and transferring samples - Google Patents
Method and device for collecting, preserving and transferring samples Download PDFInfo
- Publication number
- GB2572359A GB2572359A GB1804903.1A GB201804903A GB2572359A GB 2572359 A GB2572359 A GB 2572359A GB 201804903 A GB201804903 A GB 201804903A GB 2572359 A GB2572359 A GB 2572359A
- Authority
- GB
- United Kingdom
- Prior art keywords
- head
- sample
- flocked
- swab
- collecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5029—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures using swabs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/38—Swabs having a stick-type handle, e.g. cotton tips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/16—Surface properties and coatings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N2001/028—Sampling from a surface, swabbing, vaporising
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A method for collecting a biological sample, such as a forensic sample, using a swab. The swab has a handle with an end or tip that is coated with fibres (e.g. polyester fibres) that form an absorbent flocked head. The head has a surface area of 3 to 80 mm2 and fits into a 10-200 microlitre volume reaction well/tube. The biological sample comprising nucleic acid is collected on the head by contacting the head and the sample. Amplification is carried out on the nucleic acid in the sample. The flocked head may be a sphere or drop-shape and have a diameter of 1 to 6 millimeters. The flocked head can be treated with a predetermined concentration of chaotropic agent(s), such as 500 to 1500 mM guanidium thiocyanate. Treatment can be contacting the flocked head with a solution of the chaotropic agent(s) before collecting the biological sample. The nucleic acid sample may be contacted with a solution of the chaotropic agents before adding the flocked head for collecting the sample. The sample may or may not be released from the head before amplification. Alternatively, the fibres may be coated with a chaotropic agent.
Description
Method and device for collecting, preserving and transferring samples
Field of the invention
The present invention is within the field of molecular biology. More closely it relates to a flocked swab for use in a method for collecting, preserving and transferring biological samples in trace amounts for subsequent molecular biology analysis.
Background of the invention
Long-term storage, transport and archiving of nucleic acids on filter paper or chemically modified matrices is a well-known technique for preserving genetic material before the DNA or RNA is extracted and isolated in a form for use in genetic analysis such as PCR. Thus, EP 1563091 (Smith et al, Whatman) relates to methods for storing nucleic acids from samples such as cells or cell lysates. The nucleic acid is isolated and stored for extended periods of time, at room temperature and humidity, on a wide variety of filters and other types of solid support or solid phase media.
In the collection of nucleic acids for subsequent analysis, the challenge is to collect as much sample (e.g., DNA from a crime scene) as possible, to allow maximum yield available for amplification.
Within prior art sample collection has been done by swabbing using a flocked fiber swab but the recovery of sampled amounts are often low and may vary. When a DNA extraction process is used to extract DNA from the swab, % recovery is usually not as high as expected and can be variable.
US 6168922 describes a device and method for storing and purifying nucleic acids from a biological source, comprising and adsorbent material having impregnatead chaotropic salts. The nucleic acids are eluted from the adsorbent material while amplification inhibitors, such as proteins, from the biological sample remain bound to the adsorbent.
US 9040675 relates RSM (RNA Stabilisation Matrix) chemicals used on a solid matrix for the extraction and storage of nucleic acids from a sample, such as a biological sample wherein a composition comprising o protein denaturant, a reducing agent, a buffer, and optionally a free-radical trap or RNase inhibitor is present in the solid matrix in a dried format
However, methods and devices that integrate nucleic acid extraction, stabilization, and storage/preservation from a biological sample within a single process with high yield are still highly desirable and needed.
Summary of the invention
The present invention provides a device and method for sample collection of optimal amounts of nucleic acid for subsequent analysis. The invention provides a flocked fibre collection swab of sufficient volume to collect enough sample for subsequent nucleic acid analysis. The flocked swab is either pre-treated with a solution comprising chaotropic agent(s) or dipped in such a solution before sampling. The chemistry of the solution serves to increase the quantity of sample retrieved, and stabilise and protect genetic material from degradation.
The low recovery and variation within prior art, is increased/improved according to the present invention where the swab can be used directly in an amplification reaction, such as 'direct' PCR. Also, addition of chaotrope increases DNA yield.
The flocked swabs used in the invention are provided on a tip or head of solid shaft, such as molded plastic applicator shaft. The head or tip may vary in size and shape and is coated with short polyester, such as nylon, fibers that are arranged in a perpendicular fashion on the tip. The flocked swab is a specimen collection device with tufts of polyester material attached to one end of a plastic shaft; used to collect forensic and biological specimens such as blood, saliva, semen, skin, bone or hair cells, bacterial and viral pathogens. The flocked swabs allow a greater amount of specimen to be collected and remain on the surface of the fiber for complete elution in the transport, assay or processing medium. The complex webbing of flock fibers collect and maintain more specimen and they then release it faster and more completely than traditional fiber swabs.
The surface area of a flocked swab is increased compared to traditional spun fiber swabs, also the sample is more readily released. The shape of the head or tip may be spherical or teardrop. Sphere volume = 4/3ΡΪ r3, teardrop volume = 2/9 Pi r2 r3 h (where r is the radius of the spherical part, and h is the height of conical part].
In a first aspect, the invention relates to a method for collecting a biological sample, such as a forensic sample or a crime scene sample, the method comprising the steps of a) providing a swab including a handle wherein one tip or end of the handle is coated with fibres , such as polyester fibres, like nylon, to form an absorbent flocked head, wherein the head having a surface area of 3-80 mm2 , such as 3.14mm2 and 78.54mm2 (surface area calculated for a sphere) and that the swab head would fit into a small volume reaction well/tube, such as 10-200 pl, preferably 25-50 pl;
b) collecting a biological sample comprising nucleic acid on the head by contact between the head and the sample,
c) subjecting the nucleic acid in the sample to nucleic acid (NA) amplification.
The reason for the head size is that a small flocked swab is ideal for the collection of a small quantity of sample / trace evidence, such as touch DNA, skin cells, gunshot residue etc. Also, swab must be small enough to fit into 25uI PCR volume to allow 'direct' PCR, but of sufficient size to collect adequate quantity of NA through swabbing process.
The biological sample may be body fluid or tissue and may comprise a buccal swab, a saliva sample, a serum sample, a plasma sample, a feces sample, a urine sample, a spinal fluid sample, a sputum sample, a sperm sample, lymphatic fluid, or a suspension of cells or viruses.
The flocked head is preferably sphere or drop shape and has a diameter of 1-5 mm.
In one embodiment the flocked head is treated with a predetermined concentration of chaotropic agent(s).
In another embodiment, the flocked head is contacted with a solution with a predetermined concentration of chaotropic agent(s) before collecting the sample. In this embodiment the head is wet before sampling
In a further embodiment, the nucleic acid sample is contacted with a solution with a predetermined concentration of chaotropic agent(s) before adding the flocked head for collecting the sample
The chaotropic agents are preferably selected from chaotropic salt(s) comprising an iodide salt or a guanidinium salt, such as guanidinium salt comprises guanidine hydrochloride, guanidine isothiocyanate, or guanidine thiocyanate, and optionally RSM (RNA Stabilisation Matrix) chemicals: a protein denaturant, a reducing agent, a buffer, and optionally a freeradical trap or RNase inhibitor is present in the solid matrix in a dried format.
Preferably the concentration of the solution is 500 - 1500 mM Guanidinium thiocynate. Optionally, the solution further comprises 10 - 50 mM MOPS.
The invention enables collection of 10 pg- 1000 ng nucleic acid is collected in step b) of the method of the invention described above.
In one embodiment of the method the sample in step c) is not released before amplification. In another embodiment the sample in step c) is released before amplification.
In a second aspect, the invention relates to a collection swab comprising a shaft with a flocked head in one end, said head having a diameter of 1-6 mm and surface area between 3mm2 and 80 mm2 obtained by flocked polyester fibers provided on the head.
Preferably the collection swab has fibres that are coated with a chaotropic agent.
The coating is with an iodide salt or a guanidinium salt, such as guanidinium salt comprises guanidine hydrochloride, guanidine isothiocyanate, or guanidine thiocyanate, and optionally RSM (RNA Stabilisation Matrix) chemicals: a protein denaturant, a reducing agent, a buffer, and optionally a free-radical trap or RNase inhibitor is present in the solid matrix in a dried format. Preferably the concentration of the solution applied to the flocked head is 500 1500 mM Guanidinium thiocynate, preferably also comprising 10 - 50 mM MOPS.
Detailed description of the invention
The present disclosure generally relates to methods and devices that integrate the steps of nucleic acid extraction and stabilization from a biological specimen collected on a solid matrix. The nucleic acids are released from the devices (flocked swab) at the time of analysis thereof.
The sample collecting device of the invention has at least two advantages over current swab formats:
a. The swab head/fibres will either be pre-treated/coated reagents and preservative to stabilise and protect genetic material from degradation. Reagents would include a chaotrope such as Guanidinium thiocynate. Alternatively, a buffer containing a chaotrope could be applied to the swab or sample area prior to swabbing. Experiments have demonstrated use of a buffer containing Guanidinium thiocynate and MOPS increased DNA yield by up to 30% when compared to uncoated swabs or application of water to the sample area.
b. The swab head will be small enough to be used for 'direct' PCR, therefore the swab can be added directly to the PCR reaction, it will not need to undergo lengthy, inefficient extraction processes to remove the sample e.g., DNA from the swab. The whole sample will go into the amplification/PCR/STR reaction, therefore reducing loss of DNA, which could potentially be scarce if e.g., collected from a crime scene.
EXPERIMENTAL
The below Experiments describe preparation and use of a flocked swab for collecting, preserving and transferring trace samples for molecular biology.
Experiment 1.
Aim:
To evaluate optimal concentration of Guanidinium thiocynate / MOPS buffer (GITC buffer) to use in Powerplex 18D STR profiling reactions (Promega DC1808).
Methods:
A 100% GITC buffer was prepared, containing 2.538 M Guanidinium thiocynate and 72 mM MOPS, pH ~7.5. This was diluted and lul aliquots were used to spike Powerplex 18D STR profiling reactions containing 250pg or Ing purified gDNA.
Results:
The results are shown in Table 1 below.
Table 1
Sample Name | Sample info | APH (Average Peak Height) | Number of Alleles | Number of PHR <0.6 | Mean APH |
1 | lul 10% GITC buffer per rxn | 4728.806 | 31 | 1 | |
Ing gDNA | 2933.103 | 29 | 2 | 3716.8 | |
3488.387 | 31 | 0 | |||
2 | lul 20% GITC buffer per rxn | 5016.645 | 31 | 0 | |
Ing gDNA | 5359.226 | 31 | 0 | 5080.0 | |
4864.226 | 31 | 0 | |||
3 | lul 30% GITC buffer per rxn | 4936.161 | 31 | 0 | |
Ing gDNA | 5636.032 | 31 | 0 | 5351.5 | |
5482.355 | 31 | 0 | |||
4 | lul 40% GITC buffer per rxn | 6313.419 | 31 | 0 | |
Ing gDNA | 6703.355 | 31 | 1 | 6282.9 | |
5831.968 | 31 | 1 | |||
5 | lul 50% GITC buffer per rxn | 6666.645 | 31 | 0 | |
Ing gDNA | 6012.226 | 31 | 0 | 6459.4 | |
6699.29 | 31 | 1 | |||
6 | Ing control | 5820 | 31 | 0 | |
NO GITC buffer | 5731.677 | 31 | 0 | 5632.0 | |
Ing gDNA | 5344.226 | 31 | 0 |
7 | lul 40% GITC buffer per rxn | 1689.839 | 31 | 0 | |
250pg gDNA | 1845 | 31 | 0 | 1781.2 | |
1808.903 | 31 | 0 | |||
8 | lul 20% GITC buffer per rxn | 2258.742 | 31 | 0 | |
250pg gDNA | 2025.871 | 31 | 4 | 2121.4 | |
2079.484 | 31 | 3 | |||
9 | 250pg control | 1314.742 | 31 | 1 | |
NO GITC buffer | 1411.968 | 31 | 1 | 1295.7 | |
250pg gDNA | 1160.35 | 31 | 2 | ||
10 | NTC | 0 | 0 | 1 | |
NO GITC buffer | 0 | 0 | 1 | 0.0 | |
NOgDNA | 0 | 0 | 1 |
Conclusions:
The present inventors hove found on ideal range for optimal concentration of GITC buffer and gDNA concentration. The optimal range of GITC buffer concentration appears to be ~ 507.6 - 1269 mM Guanidinium thiocynate and 14.4 - 36 mM MOPS applied to the swab (and therefore added to the PCR reaction). The sampled gDNA concentration should be within 10 pg and 1000 ng.
Note: 60% GITC buffer was previously trialed (data not shown), this concentration inhibited the PCR reaction.
Ing gDNA:- • Presence of GITC buffer (40 & 50%) appears to increase Peak Height (APH) compared to no GITC control.
250pg gDNA:- • Presence of GITC buffer (40 & 20%) appears to increase Peak Height (APH) compared to no GITC control.
• 100% First Pass Yield obtained - 31 alleles were called for all samples.
Experiment 2.
Aim:
To determine whether Guonidinium thiocynate I MOPS buffer (GITC buffer) improves DNA yield following recovery using small swabs suitable for 'direct' PCR. Two approaches were used, as described below.
Note: 100% GITC buffer contains 2.538 M Guanidinium thiocynate and 72 mM MOPS, pH -7.5
Methods:
1. Swabs coated with GITC buffer and used to recover 'dried' qDNA:-
5uI GITC buffer was pipetted onto the tip of each swab head and was left to dry in a desiccator overnight. The following day, the swabs were used to collect Ing gDNA that had been dried onto a surface (see below for details).
Note: gDNA collection involved swabbing the area where the gDNA was applied for 10 seconds.
IA. 5ul of 4% GITC buffer pipetted onto swab heads.
5ul of a 4% GITC buffer equates to -507.6 mM Guanidinium thiocynate and 14.4 mM MOPS applied to the swab (and added to the PCR reaction).
IB. 5ul of 8% GITC buffer pipetted onto swab heads.
5ul of an 8% GITC buffer equates to -1015.2 mM Guanidinium thiocynate and 28.8 mM MOPS applied to the swab (and added to the PCR reaction).
IC. No GITC control - uncoated swabs were used.
2. GITC buffer pipetted onto 'dried1 gDNA sample & uncoated swab used to recover qDNA:5uI GITC buffer was dispensed onto Ing gDNA that had been 'dried' onto a surface (*as described below). Uncoated swabs were then used to collect the gDNA.
Note: gDNA collection involved swabbing the area where the gDNA was applied for 10 seconds.
2A. 5ul water dispensed onto 'dried' gDNA samples.
2B. 5uI of 4% GITC buffer was pipetted onto 'dried' gDNA samples.
5uI of a 4% GITC buffer equates to -507.6 mM Guanidinium thiocynate and 14.4 mM MOPS applied to the swab (and added to the PCR reaction).
2C. 5uI of 8% GITC buffer was pipetted onto 'dried' gDNA samples.
5ul of an 8% GITC buffer equates to -1015.2 mM Guanidinium thiocynate and 28.8 mM MOPS applied to the swab (and added to the PCR reaction).
2D. 5ul of 0.1% SDS solution was pipetted onto 'dried' gDNA samples.
3. Uncoated swabs stored in GITC buffer post sample collection:-
3A. unceated swabs placed in 25uI 4% GITC post sample collection.
3B. uncoated swabs placed in 25uI 8% GITC post sample collection.
3C. uncoated swabs stored 'dry' post sample collection.
Swab details:
Custom 'flocked' swabs were provided by Puritan. Swab heads were -2.7 mm x 5.4 mm in size (semi-sphere or spherical cap shaped) The flocking material was nylon.
NOTE: post gDNA collection, all swabs were cut with a scalpel to remove the lower
-l/3rd of the bud. This was placed directly into the PCR reaction.
^Preparation of Ing gDNA 'dried' samples:4uI aliquots of gDNA @250pg/uI (Ing total gDNA per spot) were aliquoted onto Petri dishes and left to dry overnight (with the lid on).
Note: the base of the Petri dishes had small circles ~5mm in diameter drawn on them with a marker pen & gDNA was placed within the circle.
When swabbed - the swab was rubbed over the area of the circle for 10 seconds.
4. Experimental controls:
4A. Positive control: Ing gDNA in 25uI PP18D STR reaction.
4B. Ing gDNA in 25uI PP18D STR reaction + lul 20% GITC buffer
4C. Ing gDNA in 25uI PP18D STR reaction + lul 40% GITC buffer
4D. Ing gDNA in 25uI PP18D STR reaction + lul 20% GITC buffer + uncoated swab
4E. Ing gDNA in 25uI PP18D STR reaction + lul 40% GITC buffer + uncoated swab
4F. NTC: NO gDNA in 25ul PP18D STR reaction.
Results
The results are described below in Table 2.
Table 2
Sample Name | APH (Average Peak Height) | Number of Alleles | Number of PHR <0.6 | Mean APH | % of Ing liquid control (4A) | |
1A | 1205.8 | 33.0 | 3 | 4% GITC | % of liquid control + 20% GITC in rxn | |
1A | 1253.1 | 33.0 | 1 | 1514.8 | 30.0 | (4B) |
1A | 1130.6 | 33.0 | 1 | 28.23 | ||
1A | 2469.9 | 33.0 | 1 | |||
IB | 736.2 | 22.0 | 1 | 8% GITC | % of liquid control | |
IB | 1027.2 | 29.0 | 0 | 1038.0 | 20.6 | +40% GITC (4C) |
IB | 1766.9 | 25.0 | 1 | 17.61 | ||
IB | 621.9 | 15.0 | 1 | |||
1C | 576.0 | 33.0 | 3 | NO GITC | % of Ing liquid control, no GITC | |
1C | 638.1 | 33.0 | 2 | 525.5 | 10.4 | (4A) |
1C | 306.8 | 33.0 | 2 | 10.42 | ||
1C | 581.1 | 33.0 | 2 | |||
2A | 2990.4 | 33.0 | 0 | water | % of Ing liquid control, no GITC | |
2A | 1935.4 | 33.0 | 0 | 2482.3 | 49.2 | (4A) |
2A | 2521.2 | 33.0 | 0 | 49.2 | ||
2B | 3194.5 | 33.0 | 0 | 4% GITC | % of liquid control + 20% GITC in rxn | |
2B | 2772.7 | 33.0 | 2 | 2887.8 | 57.2 | (4B) |
2B | 2696.1 | 33.0 | 0 | 53.81 | ||
2C | 2405.8 | 33.0 | 1 | 8% GITC | % of liquid control | |
2C | 603.5 | 11.0 | 1 | 1423.7 | 28.2 | +40% GITC (4C) |
2C | 1261.8 | 25.0 | 2 | 24.16 | ||
2D | 1776.9 | 33.0 | 0 | SDS | Note: 5ul of 4% | |
GITC = 20% in | ||||||
2D | 1902.3 | 33.0 | 0 | 1933.0 | 38.3 | reaction |
2D | 2119.7 | 33.0 | 0 | ||
3A | 166.9 | 20.0 | 0 | ||
3A | 170.3 | 32.0 | 6 | 173.8 | |
3A | 184.4 | 30.0 | 0 | ||
3B | 97.0 | 1.0 | 0 | ||
3B | 112.0 | 1.0 | 0 | 111.4 | |
3B | 125.2 | 6.0 | 1 | ||
3C | 424.9 | 33.0 | 2 | ||
3C | 887.2 | 33.0 | 0 | 437.4 | |
3C | 0.0 | 0.0 | 0 | ||
4A | 4514.4 | 33.0 | 0 | ||
4A | 4919.9 | 33.0 | 0 | 5045.3 | |
4A | 5222.5 | 33.0 | 0 | ||
4A | 5524.5 | 33.0 | 0 | ||
4B | 5610.9 | 33.0 | 0 | 5366.3 | 106.4 |
4B | 5121.8 | 33.0 | 0 | ||
4C | 5987.8 | 33.0 | 0 | 5893.0 | 116.8 |
4C | 5798.2 | 33.0 | 0 | ||
4D | 2314.1 | 32.0 | 1 | 2922.2 | 57.9 |
4D | 3530.2 | 33.0 | 0 | ||
4E | 2867.1 | 33.0 | 0 | 2867.1 | 56.8 |
5ul of 8% GITC =
40% in reaction
Conclusions:5
Experiment 1:
• Swabs coated with 5uI of 4% GITC buffer collected 3X more DNA than uncoated swabs. Full STR profiles (i.e., 33 alleles) were obtained for all samples, however some heterozygous alleles produced Peak Height Ratio's (PHR's) below 0.6.
• Swabs coated with 5uI of 8% GITC buffer collected 2X more DNA than uncoated swabs, however full STR profiles were not obtained for the 4 samples tested.
Experiment 2:
· Application of 5ul 4% GITC buffer to dried gDNA prior to swabbing yielded ~8% more
DNA than use of water. Full STR profiles (i.e., 33 alleles) were obtained for all samples and all heterozygous alleles produced Peak Height Ratio's (PHR's) above 0.6.
• Application of Sul 8% GITC buffer to dried gDNA prior to swabbing yielded -21% less DNA than use of water.
• Application of 5uI 0.1% SDS to dried gDNA prior to swabbing yielded -11% less DNA than use of water.
Other observations:
• Addition of GITC buffer directly to STR reactions enhanced Average Peak Height (APH) by -6 -15% (samples 4B & 4C) • Addition of swabs directly to STR reactions decreased Average Peak Height (APH) by
-40% - however, full STR profiles (i.e., 33 alleles) were still obtained.
As discussed in Experiment 1, there appears to be an ideal spot for optimal concentration of
GITC buffer and gDNA concentration. The optimal range of GITC buffer concentration appears to be - 507.6 - 1269 mM Guanidinium thiocynate and 14.4 - 36 mM MOPS applied 15 to the swab (and therefore added to the PCR reaction). This equates to lul of 20% - 50%
GITC buffer used in a PCR reaction (or 5uI of 4% -10% GITC buffer used in a PCR reaction).
Claims (16)
1. A method for collecting a biological sample, the method comprising the steps of a) providing a swab including a handle wherein one tip or end of the handle is coated with
5 fibres , such as polyester fibres, to form an absorbent flocked head, wherein the head having a surface area of 3-80 mm2 and wherein the swab head fits into a 10-200 pl volume reaction well/tube;
b) collecting a biological sample comprising nucleic acid on the head by contact between the head and the sample,
10 c) subjecting the nucleic acid in the sample to nucleic acid (NA) amplification.
2. Method according to claim 1, wherein the flocked head is sphere or drop shaped and has a diameter of 1-6 mm..
15
3. Method according to claim 1 or 2, wherein the flocked head is treated with a predetermined concentration of chaotropic agent(s).
4. Method according to claim 1, 2 or 3, wherein the flocked head is contacted with a solution with a predetermined concentration of chaotropic agent(s) before collecting the sample.
5. Method according to claim 1 or 2, wherein the nucleic acid sample is contacted with a solution with a predetermined concentration of chaotropic agent(s) before adding the flocked head for collecting the sample.
256. Method according to claim 3,4 or 5, wherein the chaotropic agents are selected from chaotropic salt(s) comprising an iodide salt or a guanidinium salt, such as guanidinium salt comprises guanidine hydrochloride, guanidine isothiocyanate, or guanidine thiocyanate, and optionally RSM (RNA Stabilisation Matrix) chemicals : a protein denaturant, a reducing agent, a buffer, and optionally a free-radical trap or RNase inhibitor is present in the solid 30 matrix in a dried format.
7. Method according to any of the claims 3-6, wherein the concentration of the solution is 500 - 1500 mM Guanidinium thiocynate.
35
8. Method according to claim 7, wherein the solution further comprises 10 - 50 mM MOPS.
9. Method according to one or more of the above claims, wherein 10 pg- 1000 ng nucleic acid is collected in step b).
10. Method according to one or more of the above claims, wherein the sample in step c) is not released before amplification.
11. Method according to one or more of the above claims, wherein the sample in step c) is released before amplification.
12. A collection swab comprising a handle with a flocked head in one end, said head having a diameter of 1-6 mm and surface area between 3 mm2 and 80 mm2 obtained by flocked polyester fibers provided on the head.
13. Collection swab according to claim 12, wherein the fibres are coated with a chaotropic agent.
14. Collection swab according to claim 13, wherein the coating is with an iodide salt or a guanidinium salt, such as guanidinium salt comprises guanidine hydrochloride, guanidine isothiocyanate, or guanidine thiocyanate, and optionally RSM (RNA Stabilisation Matrix) chemicals : a protein denaturant, a reducing agent, a buffer, and optionally a free-radical trap or RNase inhibitor is present in the solid matrix in a dried format.
15. Collection swab according to claim 12,13 or 14, wherein the concentration of the solution applied to the flocked head is 500 - 1500 mM Guanidinium thiocynate, preferably also comprising 10 - 50 mM MOPS.
16. Use of a flocked swab according to claim 12-15 for collecting biological samples comprising nucleic acids and preserving said samples until subsequent analysis thereof.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1804903.1A GB2572359A (en) | 2018-03-27 | 2018-03-27 | Method and device for collecting, preserving and transferring samples |
PCT/EP2019/050688 WO2019185208A1 (en) | 2018-03-27 | 2019-01-11 | Method and device for collecting, preserving and transferring samples |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1804903.1A GB2572359A (en) | 2018-03-27 | 2018-03-27 | Method and device for collecting, preserving and transferring samples |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201804903D0 GB201804903D0 (en) | 2018-05-09 |
GB2572359A true GB2572359A (en) | 2019-10-02 |
Family
ID=62068056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1804903.1A Withdrawn GB2572359A (en) | 2018-03-27 | 2018-03-27 | Method and device for collecting, preserving and transferring samples |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2572359A (en) |
WO (1) | WO2019185208A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939259A (en) * | 1997-04-09 | 1999-08-17 | Schleicher & Schuell, Inc. | Methods and devices for collecting and storing clinical samples for genetic analysis |
WO2004086979A1 (en) * | 2003-04-01 | 2004-10-14 | Copan Innovation Limited | Swab for collecting biological specimens |
US20100106057A1 (en) * | 2007-02-16 | 2010-04-29 | Harvey Michael A | Controlled transfer biological sample collection devices and methods of using such devices |
US20140017676A1 (en) * | 2012-07-13 | 2014-01-16 | Diomics Corporation | Biologic sample collection devices and methods of production and use thereof |
US20170137874A1 (en) * | 2014-03-26 | 2017-05-18 | General Electric Company | Solid phase isothermal amplification |
CN107299049A (en) * | 2017-07-06 | 2017-10-27 | 浙江晟景生物技术有限公司 | The oral cavity cell DNA extracts kit of baby |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3033047B1 (en) * | 2015-02-20 | 2017-07-14 | L'etat Francais Represente Par Le Mini De L'interieur | COLLECTION DEVICES FOR THE DIRECT AND INDIRECT FAST ANALYSIS OF NUCLEIC ACIDS FROM BIOLOGICAL TRACES |
US10000742B2 (en) * | 2015-11-19 | 2018-06-19 | General Electric Company | Device and method of collection for RNA viruses |
WO2017210748A1 (en) * | 2016-06-10 | 2017-12-14 | Flinders University Of South Australia | Nucleic acid collection device and method |
-
2018
- 2018-03-27 GB GB1804903.1A patent/GB2572359A/en not_active Withdrawn
-
2019
- 2019-01-11 WO PCT/EP2019/050688 patent/WO2019185208A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939259A (en) * | 1997-04-09 | 1999-08-17 | Schleicher & Schuell, Inc. | Methods and devices for collecting and storing clinical samples for genetic analysis |
WO2004086979A1 (en) * | 2003-04-01 | 2004-10-14 | Copan Innovation Limited | Swab for collecting biological specimens |
US20100106057A1 (en) * | 2007-02-16 | 2010-04-29 | Harvey Michael A | Controlled transfer biological sample collection devices and methods of using such devices |
US20140017676A1 (en) * | 2012-07-13 | 2014-01-16 | Diomics Corporation | Biologic sample collection devices and methods of production and use thereof |
US20170137874A1 (en) * | 2014-03-26 | 2017-05-18 | General Electric Company | Solid phase isothermal amplification |
CN107299049A (en) * | 2017-07-06 | 2017-10-27 | 浙江晟景生物技术有限公司 | The oral cavity cell DNA extracts kit of baby |
Also Published As
Publication number | Publication date |
---|---|
WO2019185208A1 (en) | 2019-10-03 |
GB201804903D0 (en) | 2018-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6254117B2 (en) | Controlled transfer biological sampling device and method of using the device | |
EP2108110B1 (en) | Device for collecting and triggered release of a biological sample | |
EP2861347B1 (en) | Biologic sample collection devices and methods of production and use thereof | |
JP2022089877A (en) | Systems, methods, and devices for sample collection, stabilization and preservation | |
EP2521780B1 (en) | A method for isolation of nucleic acids and a kit thereof | |
US10837010B2 (en) | Porous solid phase for rapidly isolating biological molecules for nucleic acid amplification reaction from biological sample, and use thereof | |
HUE026122T2 (en) | Method for isolating short chain nucleic acids | |
EP1552005A1 (en) | Apparatus and method for isolating a nucleic acid from a sample | |
JP2011236237A (en) | Stable protein storage and stable nucleic acid storage in recoverable form | |
WO1990003959A1 (en) | Solid medium and method for dna storage | |
US20210363514A1 (en) | Syringe-type nucleic acid extraction apparatus, nucleic acid extraction kit and nucleic acid extraction method therewith | |
GB2572359A (en) | Method and device for collecting, preserving and transferring samples | |
WO2013125141A1 (en) | Plant tissue sampling method and plant gene analysis method | |
US20070059751A1 (en) | Nucleic acid isolation method | |
US10809163B2 (en) | Device for collecting biological material from a biological trace | |
US20230054102A1 (en) | Liquid- and swab-based collection devices for collecting and preserving biological material | |
WO2022268725A2 (en) | Sample preparation | |
CN117769463A (en) | Sample preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20191205 AND 20191211 |
|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |